The half-life of human procathepsin S

Eur J Biochem. 1999 Aug;263(3):717-25. doi: 10.1046/j.1432-1327.1999.00547.x.

Abstract

Two processes, synthesis and degradation, contribute to the intracellular concentration of a protein. As most malignant tumors or tumor cell lines show elevated levels of proteinases, we studied the half-life of a cysteine proteinase, procathepsin S, in order to determine whether tumor cells can regulate their cathepsin concentration via changing the degradation rate of the enzyme. The following procathepsin S species were examined: wild-type procathepsin S in macrophages, recombinant procathepsin S in human embryonic kidney cells (HEK 293 cells), recombinant nonglycosylated procathepsin S in HEK 293 cells, wild-type procathepsin S in the established nonsmall cell lung carcinoma cell line 97TM1. The half-lives of both wild-type procathepsins S expressed in macrophages and in HEK 293 cells were 1 h, whereas that of procathepsin S in the tumor cell line was 2 h. Nonglycosylated procathepsin S was not processed. The degradation of mature cathepsin S proceeded with a half-life of 16-18 h. All cell lines studied secreted substantial amounts of procathepsin S into the culture medium. No further maturation of secreted procathepsin S has been observed in the culture medium. We suggest a disturbed sorting mechanism in tumor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Non-Small-Cell Lung
  • Cathepsins / genetics
  • Cathepsins / metabolism*
  • Cell Line
  • Enzyme Precursors / genetics
  • Enzyme Precursors / metabolism*
  • Glycosylation
  • Half-Life
  • Humans
  • Kidney
  • Kinetics
  • Luminescent Measurements
  • Lung Neoplasms
  • Macrophages / enzymology*
  • Recombinant Proteins / metabolism
  • Tumor Cells, Cultured

Substances

  • Enzyme Precursors
  • Recombinant Proteins
  • Cathepsins
  • cathepsin S